Haemonetics Corp. (hae 0 03/01/26)
13F holders, Q2 2024 (June 30)6holders −1
1new positions
2sold out
$0.90avg. 13F price*
At the end of Q2 2024, 6 institutions reported holding Haemonetics Corp. (hae 0 03/01/26) in their 13F filings, down 1 from Q1 2024. 1 opened new positions and 2 sold out. The largest holders were BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($5.4M), Toronto Dominion Bank ($2.7M) and Sei Investments Co. ($300K).
- Company
- Haemonetics Corp. (hae 0 03/01/26)
- CUSIP
- 405024AB6
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $45K |
| Exits | 2 | $6.4M |
All 13F filers, Q1 2024 → Q2 2024: 140,000 shares bought and 6,926,000 shares sold, net −6,786,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.01% | No change | 6,000,000 | $5.4M |
| Toronto Dominion Bank | 0.00% | No change | 3,000,000 | $2.7M |
| Sei Investments Co. | 0.00% | No change | 335,000 | $300K |
| Oppenheimer Asset Management Inc. | 0.00% | Add +69.2% | 220,000 | $197K |
| Stephens Inc. | 0.00% | Reduce -1.7% | 116,000 | $104K |
| Jane Street Group, LLC | 0.00% | New | 50,000 | $45K |
"% of holder's portfolio" is HAEMONETICS CORP (HAE 0 03/01/26)'s weight in each manager's 13F, not the share of Haemonetics Corp. (hae 0 03/01/26) the manager owns.